RNF157 Activators
RNF157 Activators are a collection of chemical compounds that serve to enhance the functional activity of RNF157 through various indirect mechanisms within cellular signaling pathways. Forskolin, through its ability to elevate intracellular cAMP levels, leads to the activation of protein kinase A (PKA), which has the potential to phosphorylate regulatory proteins that can increase the ubiquitination activity of RNF157. Similarly, the action of Sphingosine-1-phosphate (S1P) via its G-protein-coupled receptors activates the PI3K/AKT pathway, a signaling cascade that can enhance the stability or substrate recognition of RNF157, thereby augmenting its ligase function. Ionomycin, with its capacity to raise intracellular calcium levels, might influence RNF157 by modulating calcium-dependent signaling pathways, and Phorbol 12-myristate 13-acetate (PMA), as a PKC activator, may potentiate RNF157's ubiquitination activity through protein phosphorylation.
Furthermore, inhibitors such as Epigallocatechin gallate (EGCG) and Wortmannin, by modulating protein kinase and PI3K activities, respectively, can indirectly upregulate RNF157's function by alleviating inhibitory phosphorylations on pathways competing with those associated with RNF157. U0126, which targets MEK1/2, alters key signaling nodes that can shift the cellular equilibrium toward enhancing RNF157's ubiquitination processes. Thapsigargin, by perturbing calcium homeostasis, and Staurosporine, through broad-spectrum kinase inhibition, each contribute by activating regulatory proteins or lifting the inhibition on RNF157-associated pathways. Collectively, these activators manipulate the signaling landscape to favor the functional activity of RNF157 without necessitating direct upregulation or modification of the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels which can lead to the activation of PKA. PKA can then phosphorylate proteins that regulate the activity of E3 ubiquitin-protein ligases like RNF157, potentially enhancing its ubiquitination activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P interacts with its G-protein-coupled receptors to activate downstream signaling pathways such as PI3K/AKT. Activation of AKT can then enhance the function of RNF157 by promoting its stability or its substrate recognition efficiency. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can modulate calcium-dependent signaling pathways that might enhance the enzymatic activity of RNF157 by altering its conformation or interaction with substrates. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cAMP analog that activates cAMP-dependent pathways, including PKA. PKA activation can result in increased RNF157 activity by phosphorylation of either RNF157 or associated regulatory proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate proteins that modulate the function of RNF157, potentially increasing its ubiquitin ligase activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, which may reduce competitive signaling pathways, thereby indirectly upregulating RNF157 activity through relief of inhibitory phosphorylation events. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). Disrupted calcium signaling may enhance RNF157's role by activating calcium-dependent proteins that regulate RNF157's ligase activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, which can lead to modulation of the AKT pathway, potentially enhancing RNF157's ubiquitin ligase activity by altering its interaction with substrates. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum protein kinase inhibitor, might lead to the selective activation of RNF157 by preventing the phosphorylation-based inhibition of RNF157 or proteins that regulate RNF157 activity. | ||||||